¶ Mitochondrial Dynamics Pathway: Fusion and Fission in Neurodegeneration
Mitochondrial Dynamics Pathway: Fusion And Fission In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mitochondrial dynamics refers to the continuous processes of mitochondrial fusion (combining two mitochondria into one) and fission (dividing one mitochondria into two). These opposing processes maintain mitochondrial morphology, distribution, and quality control within cells. The balance between fusion and fission is crucial for neuronal health, as neurons are highly energy-dependent cells with unique mitochondrial requirements for synaptic function, axonal transport, and survival.
In neurodegenerative diseases, mitochondrial dynamics are severely dysregulated, leading to fragmented mitochondria, impaired energy production, and increased neuronal vulnerability. Understanding these pathways provides therapeutic targets for Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD).
Mitochondrial fusion is a multi-step process requiring coordination between the outer mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM):
Outer Membrane Fusion:
- Mitofusin 1 (MFN1) and Mitofusin 2 (MFN2): GTPase proteins on the OMM that mediate tethering and fusion of two mitochondria. MFN2 also plays roles in mitochondrial transport and ER-mitochondria contacts.
- The GTPase activity drives conformational changes that enable membrane merging.
Inner Membrane Fusion:
- OPA1 (Optic Atrophy 1): IMM GTPase critical for inner membrane fusion. OPA1 maintains cristae structure and prevents cytochrome c release during apoptosis.
- OPA1 processing (by OMA1 and YME1L proteases) generates long and short isoforms that regulate fusion activity.
Mitochondrial fission is orchestrated by dynamin-related proteins:
Core Fission Machinery:
- Drp1 (Dynamin-related protein 1): Cytosolic GTPase recruited to mitochondria. Drp1 forms ring-like structures that constrict mitochondria.
- Fis1 (Mitochondrial fission 1 protein): OMM protein that serves as a receptor for Drp1 recruitment.
- MiD49 and MiD50: Additional Drp1 receptors on the OMM.
Regulation:
- Drp1 is regulated by post-translational modifications including phosphorylation (by PKA, CDK1, CaMK1α), sumoylation, and ubiquitination.
- Mitochondrial fission is linked to mitophagy, as fission generates smaller mitochondria suitable for autophagic engulfment.
Fusion Impairment:
- MFN2 expression is significantly downregulated in AD brains
- OPA1 levels reduced, affecting cristae integrity and ATP production
- Amyloid-beta (Aβ) directly impairs mitochondrial fusion by interacting with MFN2
Fission Increase:
- Drp1 levels and activity increased in AD
- Aβ promotes Drp1 recruitment to mitochondria
- CDK5-mediated Drp1 phosphorylation enhanced in AD
Consequences:
- Fragmented mitochondria accumulate in neurons
- Impaired axonal mitochondrial transport
- Synaptic mitochondrial deficiency
- Enhanced mitophagy due to damaged mitochondria
PINK1-Parkin Connection:
- PINK1 phosphorylates MFN2, facilitating Parkin recruitment
- Parkin ubiquitinates MFN1/2, leading to their degradation
- This limits mitochondrial fusion after damage
LRRK2 Interaction:
- LRRK2 mutations (G2019S) enhance Drp1 phosphorylation
- Increased fission contributes to dopaminergic neuron vulnerability
- LRRK2 affects mitochondrial trafficking
GBA Mutations:
- Glucocerebrosidase deficiency affects mitochondrial dynamics
- Lysosomal dysfunction impacts mitophagy
- Enhanced mitochondrial fragmentation observed
TDP-43 Pathology:
- TDP-43 aggregates sequester Drp1
- Impaired mitochondrial fission machinery
- Mitochondrial transport deficits
FUS Mutations:
- FUS regulates mitochondrial dynamics genes
- Mutant FUS disrupts mitochondrial fission
- Alters Drp1 localization
SOD1 Mutations:
- Mutant SOD1 affects mitochondrial distribution
- Impaired axonal mitochondria
- Enhanced fission observed in models
Mutant HTT Effects:
- Directly interacts with mitochondria
- Impairs MFN1/2 function
- Reduces OPA1 processing
Drp1 Dysregulation:
- Drp1 recruitment enhanced
- Excessive fission fragments mitochondria
- Impaired mitochondrial quality control
Consequences:
- Energy deficit in striatal neurons
- Synaptic mitochondrial loss
- Enhanced vulnerability of medium spiny neurons
| Agent |
Mechanism |
Status |
Disease |
| MFN2 agonists |
Increase fusion |
Preclinical |
AD, PD |
| OPA1 stabilizers |
Enhance inner membrane fusion |
Preclinical |
AD, PD |
| Small molecule fusion inducers |
Promote Mfn1/2 activity |
Research |
Multiple |
| Agent |
Mechanism |
Status |
Disease |
| Drp1 inhibitors |
Block Drp1 GTPase |
Research |
PD, HD |
| PINK1 stabilizers |
Prevent excessive fission |
Preclinical |
PD |
| CDK5 inhibitors |
Reduce Drp1 phosphorylation |
Research |
AD |
- Mitophagy enhancers: Promote removal of damaged mitochondria
- Metabolic support: Improve overall mitochondrial function
- Antioxidants: Reduce oxidative stress that drives fission
- Drp1 knock-out in mice causes embryonic lethality, highlighting its essential role
- Neuron-specific Drp1 deletion causes neurodegeneration
- MFN2 mutations cause Charcot-Marie-Tooth disease type 2A
- OPA1 mutations cause dominant optic atrophy
- Post-mortem AD brain tissue shows 40% increase in Drp1 levels
- LRRK2 G2019S promotes Drp1-dependent fission
- Human iPSC models confirm fission/fusion imbalance in ALS
The study of Mitochondrial Dynamics Pathway: Fusion And Fission In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Knott AB, et al. (2008). Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci. 9(11):505-518.
- Chen H, Chan DC. (2009). Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet. 18(R2):R169-176.
- Shirendeb U, et al. (2012). Mutant huntingtin's toxic effect on synaptic mitochondrial biology is rescued by reducing mitochondrial fission. Cell Death Dis. 3:e347.
- Mancuso M, et al. (2012). Mitochondrial dynamics: minding the small mitochondria. Cell Stem Cell. 10(4):369-370.
- Itoh K, et al. (2013). Quality and quantity control of mitochondria in neurodegeneration. Adv Exp Med Biol. 804:75-92.
- Van Laar VS, Berman SB. (2013). The interplay of neuronal mitochondrial dynamics and bioenergetics in neurodegeneration. Front Aging Neurosci. 5:10.
- Burte F, et al. (2015). Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol. 11(1):11-24.
- Liu Y, et al. (2020). Mitochondrial dynamics: a potential therapeutic target for neurodegenerative diseases. Mol Neurobiol. 57(12):5025-5044.
- Lin KJ, et al. (2021). Mitochondrial dysfunction and biogenesis in the pathogenesis of Alzheimer's disease. Mol Psychiatry. 26(10):5733-5751.
- Kim HJ, et al. (2022). Mitochondrial dynamics in Parkinson's disease: a focus on LRRK2 pathogenesis. J Mov Disord. 15(2):93-100.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
33% |
| Mechanistic Completeness |
50% |
Overall Confidence: 36%